GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re ...

This study provides valuable guidance for doctors and patients when choosing diabetes medications. It confirms that ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

Researchers found that apple peels from local and commercial varieties are rich in phenolic compounds with antioxidant and ...

There has been recent interest in whether glucagon-like peptide-1 receptor agonists (GLP-1RAs) affect depression risk. One recent study found that GLP-1RAs may help lower the risk for depression ...

A new study suggests that medications commonly used for diabetes, including the popular drug Ozempic, may help reduce the ...

The federal government has spent $6.2 billion on research and development for weight-loss drugs. Now, thanks to Big Pharma ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.

Use of GLP-1 receptor agonists for obesity was associated with a reduced risk of primary open-angle glaucoma (POAG) and ...